3rd Annual Drug Discovery USA Congress 2016

Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

40 presentations and case studies focused on the key issues in drug discovery and medicinal chemistry

4 Interactive Streams:

  • Target Based Discovery
  • Screening & Assays: Enabling Technologies
  • Discovery Chemistry & Drug Design
  • Supporting Innovation: Translational Approaches & Informatics Tools

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 3rd Annual Drug Discovery USA Congress, taking place on 3-4 October 2016 in San Diego, USA. Our Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.

The drug discovery landscape is changing rapidly. With the cost of bringing a drug to market rising, researchers are seeking innovative ways to increase the efficiency of their R&D pipelines. On the first day of our Drug Discovery USA Congress our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. Our renowned speakers will explore novel peptide drug discovery, strategies for target selection and incorporating genomic technologies into discovery research. Day one also features an exciting stream covering the latest screening and assay technologies, such as novel stem cell assays, exciting new phenotypic screening strategies and how to use stem and primary cells for physiologically relevant disease models.

The pharma industry is seeing an increased focus on strengthening data and knowledge management in R&D pipelines to make the most of discovery data. Researchers are seeking new techniques to manage complex early stage discovery portfolios and for library optimisation. On day two our Congress features an exciting stream dedicated to supporting innovation with informatics tools in which we will explore new data analysis and integration platforms, as well as ideas for efficient data exchange and pre-competitive collaboration. Day two will also host discussions about the latest research in the discovery chemistry field, with exciting case studies covering computational tools for gene editing and drug design as well as fragment based drug discovery case studies.

For more information concerning the topics covered please click here

Our Discovery USA Congress builds upon the success of our prestigious Drug Discovery Leaders Summit held annually in Europe. Now entering its 17th year, our 2016 Summit will be held in Berlin on the 13-14 June 2016. For more information, please visit the official event website here

 

Drug Discovery USA and Biomarkers & Precision Medicine USA 2016 Sponsors:



 

 

del_test5del_test4del_test1del_test2sp_test3sp_test1del_test7del_test3sp_test4sp_test2del_test6

Media Partners